In the hub gene analysis, expression levels of TP53 and IGF2 were significantly elevated in STAD patients; PLG, PAPPA, AFP, and CYR61 were associated with overall survival rate; and IGFALS, PLG, IGF1, AHSG, and FN1 were associated with disease-free survival rate. Here, IGFALS is linked to gastric adenocarcinoma.